| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.598 | 0.055 | 0.823 | Beta lactamase inhibitor | 0.325 0.124 DBMET00016 0.823 0.02 DBMET00017 0.597 0.055 DBMET01048 0.648 0.046 DBMET01049 | DBMET00017 | |
| 0.503 | 0.004 | 0.503 | Histone acetyltransferase inhibitor | 0.426 0.005 DBMET00016 0.378 0.005 DBMET00017 0.286 0.016 DBMET00015 0.312 0.012 DBMET01048 0.462 0.004 DBMET01049 | ||
| 0.548 | 0.073 | 0.705 | DNA polymerase beta inhibitor | 0.313 0.159 DBMET00016 0.705 0.037 DBMET00017 0.227 0.206 DBMET00015 0.484 0.091 DBMET01048 0.495 0.088 DBMET01049 | DBMET00017 | |
| 0.447 | 0.001 | 0.447 | Dihydropteroate synthase inhibitor | 0.367 0.001 DBMET00016 0.385 0.001 DBMET00017 0.059 0.012 DBMET03017 0.2 0.002 DBMET00015 0.283 0.002 DBMET01048 0.406 0.001 DBMET01049 0.122 0.004 DBMET01050 | ||
| 0.516 | 0.076 | 0.625 | Alpha-glucosidase inhibitor | 0.5 0.081 DBMET00016 0.625 0.049 DBMET00017 0.535 0.07 DBMET03017 0.335 0.143 DBMET00015 0.614 0.051 DBMET01048 0.327 0.147 DBMET01049 | DBMET00017 | |
| 0.422 | 0.004 | 0.422 | Sodium channel blocker | 0.315 0.009 DBMET00016 0.357 0.006 DBMET00017 0.154 0.056 DBMET00015 0.24 0.021 DBMET01048 0.28 0.013 DBMET01049 | ||
| 0.489 | 0.086 | 0.619 | DNA directed DNA polymerase inhibitor | 0.33 0.147 DBMET00016 0.619 0.051 DBMET00017 0.309 0.157 DBMET00015 0.47 0.091 DBMET01048 0.392 0.119 DBMET01049 | DBMET00017 | |
| 0.407 | 0.004 | 0.447 | Carbonic anhydrase XV inhibitor | 0.447 0.004 DBMET00016 0.286 0.009 DBMET00017 0.118 0.048 DBMET00015 0.312 0.007 DBMET01048 0.175 0.023 DBMET01049 | DBMET00016 | |
| 0.381 | 0.019 | 0.381 | EphB2 antagonist | 0.194 0.092 DBMET00016 0.373 0.02 DBMET00017 0.215 0.078 DBMET00015 0.213 0.079 DBMET01048 0.299 0.036 DBMET01049 | ||
| 0.414 | 0.068 | 0.414 | 15-Lipoxygenase inhibitor | 0.23 0.182 DBMET00016 0.324 0.115 DBMET00017 0.315 0.121 DBMET01049 | ||
| 0.355 | 0.019 | 0.374 | Non-steroidal antiinflammatory agent | 0.279 0.033 DBMET00016 0.27 0.036 DBMET00017 0.374 0.017 DBMET03017 0.247 0.044 DBMET00015 0.219 0.058 DBMET01048 0.287 0.031 DBMET01049 | DBMET03017 | |
| 0.338 | 0.005 | 0.338 | Sodium channel (voltage-gated) blocker | 0.274 0.011 DBMET00016 0.295 0.009 DBMET00017 0.146 0.057 DBMET00015 0.227 0.021 DBMET01048 0.249 0.015 DBMET01049 | ||
| 0.294 | 0.017 | 0.294 | Focal adhesion kinase 2 inhibitor | 0.196 0.072 DBMET00016 0.264 0.03 DBMET00017 0.223 0.053 DBMET00015 0.16 0.115 DBMET01048 0.19 0.078 DBMET01049 | ||
| 0.309 | 0.032 | 0.309 | MAP kinase kinase 2 inhibitor | 0.253 0.052 DBMET00016 0.212 0.074 DBMET00017 0.156 0.116 DBMET01048 | ||
| 0.278 | 0.005 | 0.278 | Carbonic anhydrase IX inhibitor | 0.189 0.009 DBMET00016 0.25 0.005 DBMET00017 0.101 0.02 DBMET03017 0.097 0.021 DBMET00015 0.158 0.011 DBMET01048 0.146 0.013 DBMET01049 | ||
| 0.311 | 0.052 | 0.425 | Insulysin inhibitor | 0.24 0.106 DBMET00016 0.338 0.039 DBMET00017 0.306 0.055 DBMET00015 0.271 0.078 DBMET01048 0.256 0.09 DBMET01049 0.425 0.018 DBMET01050 | DBMET01050 | |
| 0.258 | 0.008 | 0.258 | Nav1.5 sodium channel blocker | 0.192 0.014 DBMET00016 0.191 0.014 DBMET00017 0.098 0.09 DBMET00015 0.14 0.034 DBMET01048 0.153 0.025 DBMET01049 | ||
| 0.366 | 0.123 | 0.515 | Transcription factor inhibitor | 0.24 0.194 DBMET00016 0.501 0.074 DBMET00017 0.326 0.141 DBMET00015 0.374 0.12 DBMET01048 0.515 0.071 DBMET01049 | DBMET01049 | |
| 0.245 | 0.006 | 0.245 | Carbonic anhydrase XII inhibitor | 0.159 0.011 DBMET00016 0.228 0.007 DBMET00017 0.095 0.021 DBMET03017 0.069 0.029 DBMET00015 0.142 0.013 DBMET01048 0.125 0.016 DBMET01049 | ||
| 0.244 | 0.009 | 0.274 | Carbonic anhydrase VI inhibitor | 0.274 0.007 DBMET00016 0.122 0.029 DBMET00017 0.082 0.055 DBMET00015 0.132 0.025 DBMET01048 0.098 0.04 DBMET01049 | DBMET00016 | |
| 0.247 | 0.018 | 0.303 | Hexokinase inhibitor | 0.268 0.014 DBMET00016 0.282 0.013 DBMET00017 0.226 0.023 DBMET03017 0.303 0.01 DBMET01048 0.16 0.067 DBMET01049 | DBMET01048 | |
| 0.227 | 0.005 | 0.227 | Nav1.7 sodium channel blocker | 0.172 0.008 DBMET00016 0.185 0.007 DBMET00017 0.094 0.025 DBMET00015 0.114 0.018 DBMET01048 0.179 0.008 DBMET01049 | ||
| 0.289 | 0.068 | 0.289 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.271 0.072 DBMET00017 0.224 0.087 DBMET01049 | ||
| 0.225 | 0.013 | 0.225 | Nav1.6 sodium channel blocker | 0.192 0.022 DBMET00016 0.137 0.071 DBMET00017 0.115 0.104 DBMET01048 0.139 0.067 DBMET01049 | ||
| 0.217 | 0.008 | 0.222 | Carbonic anhydrase inhibitor | 0.164 0.014 DBMET00016 0.222 0.008 DBMET00017 0.075 0.037 DBMET03017 0.097 0.028 DBMET00015 0.163 0.014 DBMET01048 0.12 0.022 DBMET01049 0.069 0.04 DBMET01050 | DBMET00017 | |
| 0.204 | 0.004 | 0.204 | Endothelin receptor antagonist | 0.167 0.004 DBMET00016 0.16 0.004 DBMET00017 0.028 0.02 DBMET03017 0.12 0.005 DBMET00015 0.119 0.005 DBMET01048 0.182 0.004 DBMET01049 0.067 0.008 DBMET01050 | ||
| 0.223 | 0.031 | 0.262 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.137 0.058 DBMET00017 0.262 0.024 DBMET01049 | DBMET01049 | |
| 0.201 | 0.014 | 0.218 | Carbonic anhydrase XIII inhibitor | 0.218 0.012 DBMET00016 0.112 0.032 DBMET00017 0.121 0.029 DBMET01048 0.079 0.051 DBMET01049 | DBMET00016 | |
| 0.221 | 0.036 | 0.221 | Antipruritic | 0.168 0.075 DBMET00016 0.202 0.047 DBMET00017 0.137 0.11 DBMET00015 0.149 0.096 DBMET01048 | ||
| 0.186 | 0.003 | 0.19 | Cyclophilin A inhibitor | 0.104 0.004 DBMET00016 0.184 0.003 DBMET00017 0.055 0.005 DBMET03017 0.143 0.003 DBMET00015 0.112 0.004 DBMET01048 0.19 0.003 DBMET01049 0.044 0.009 DBMET01050 | DBMET01049 | |
| 0.197 | 0.017 | 0.214 | Carbonic anhydrase III inhibitor | 0.214 0.014 DBMET00016 0.163 0.024 DBMET00017 0.106 0.056 DBMET00015 0.175 0.021 DBMET01048 0.106 0.056 DBMET01049 | DBMET00016 | |
| 0.182 | 0.005 | 0.182 | Bromodomain-containing protein 4 inhibitor | 0.088 0.016 DBMET00016 0.144 0.007 DBMET00017 0.099 0.013 DBMET00015 0.069 0.025 DBMET01048 0.142 0.007 DBMET01049 | ||
| 0.164 | 0.004 | 0.164 | Endothelin A receptor antagonist | 0.115 0.004 DBMET00016 0.126 0.004 DBMET00017 0.088 0.005 DBMET00015 0.078 0.005 DBMET01048 0.143 0.004 DBMET01049 0.032 0.009 DBMET01050 | ||
| 0.225 | 0.065 | 0.225 | MAP kinase kinase 3 inhibitor | 0.201 0.12 DBMET00016 | ||
| 0.193 | 0.037 | 0.193 | Cyclooxygenase 1 inhibitor | 0.151 0.056 DBMET00016 0.115 0.085 DBMET00017 0.102 0.098 DBMET03017 0.17 0.048 DBMET00015 0.163 0.05 DBMET01049 | ||
| 0.158 | 0.008 | 0.163 | Carbonic anhydrase VB inhibitor | 0.163 0.008 DBMET00016 0.091 0.018 DBMET00017 0.052 0.043 DBMET00015 0.092 0.018 DBMET01048 0.067 0.03 DBMET01049 | DBMET00016 | |
| 0.179 | 0.033 | 0.204 | Nav1.3 sodium channel blocker | 0.172 0.036 DBMET00016 0.204 0.023 DBMET00017 0.198 0.025 DBMET01048 | DBMET00017 | |
| 0.184 | 0.044 | 0.184 | Ribosomal protein S6 kinase inhibitor | |||
| 0.179 | 0.051 | 0.179 | Cyclooxygenase inhibitor | 0.138 0.08 DBMET00016 0.126 0.092 DBMET00017 0.15 0.07 DBMET00015 0.151 0.069 DBMET01049 | ||
| 0.15 | 0.022 | 0.163 | CC chemokine 6 receptor antagonist | 0.136 0.051 DBMET00016 0.144 0.032 DBMET00017 0.163 0.011 DBMET03017 0.138 0.045 DBMET00015 0.132 0.062 DBMET01048 0.15 0.022 DBMET01049 | DBMET03017 | |
| 0.139 | 0.012 | 0.145 | Carbonic anhydrase II inhibitor | 0.115 0.015 DBMET00016 0.145 0.011 DBMET00017 0.056 0.038 DBMET00015 0.116 0.015 DBMET01048 0.069 0.03 DBMET01049 | DBMET00017 | |
| 0.317 | 0.191 | 0.359 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.359 0.141 DBMET00017 0.299 0.214 DBMET01049 | DBMET00017 | |
| 0.139 | 0.017 | 0.149 | Carbonic anhydrase V inhibitor | 0.149 0.015 DBMET00016 0.132 0.019 DBMET00017 0.139 0.017 DBMET01048 0.063 0.05 DBMET01049 | DBMET00016 | |
| 0.132 | 0.015 | 0.136 | Carbonic anhydrase VA inhibitor | 0.136 0.014 DBMET00016 0.129 0.016 DBMET00017 0.13 0.015 DBMET01048 0.071 0.045 DBMET01049 | DBMET00016 | |
| 0.161 | 0.047 | 0.164 | Cyclooxygenase 2 inhibitor | 0.123 0.076 DBMET00016 0.126 0.074 DBMET00017 0.154 0.051 DBMET00015 0.164 0.045 DBMET01049 | DBMET01049 | |
| 0.139 | 0.032 | 0.139 | Ca(v)2.2 blocker | 0.074 0.071 DBMET00017 | ||
| 0.209 | 0.104 | 0.436 | Hypoglycemic | 0.19 0.122 DBMET00016 0.436 0.022 DBMET03017 0.213 0.101 DBMET01050 | DBMET03017 | |
| 0.129 | 0.03 | 0.129 | Electrolyte absorption antagonist | 0.112 0.044 DBMET00016 0.115 0.04 DBMET00017 0.099 0.059 DBMET01048 0.096 0.064 DBMET01049 | ||
| 0.14 | 0.042 | 0.184 | Falcipain 3 inhibitor | 0.184 0.023 DBMET00017 0.102 0.068 DBMET01048 | DBMET00017 | |
| 0.219 | 0.131 | 0.232 | 12-Lipoxygenase inhibitor | 0.232 0.12 DBMET00016 0.211 0.14 DBMET00017 0.224 0.127 DBMET01048 | DBMET00016 | |
| 0.113 | 0.028 | 0.115 | Bromodomain-containing protein 2 inhibitor | 0.115 0.027 DBMET00017 0.09 0.055 DBMET01049 | DBMET00017 | |
| 0.081 | 0.004 | 0.081 | Endothelin B receptor antagonist | 0.067 0.005 DBMET00016 0.057 0.005 DBMET00017 0.037 0.008 DBMET00015 0.044 0.006 DBMET01048 0.064 0.005 DBMET01049 0.019 0.013 DBMET01050 | ||
| 0.086 | 0.012 | 0.086 | Transcription factor RelA inhibitor | 0.064 0.043 DBMET00016 0.064 0.044 DBMET00017 0.074 0.024 DBMET01049 | ||
| 0.141 | 0.071 | 0.163 | Pregnane X receptor agonist | 0.123 0.121 DBMET00016 0.163 0.034 DBMET00017 0.146 0.06 DBMET01048 0.145 0.062 DBMET01049 | DBMET00017 | |
| 0.237 | 0.167 | 0.237 | GABA C receptor rho-3 antagonist | |||
| 0.076 | 0.01 | 0.076 | Bromodomain-containing protein 3 inhibitor | 0.044 0.043 DBMET00016 0.066 0.015 DBMET00017 0.058 0.023 DBMET00015 0.069 0.013 DBMET01049 | ||
| 0.158 | 0.094 | 0.158 | Lipocortins synthesis antagonist | 0.149 0.107 DBMET00016 | ||
| 0.132 | 0.074 | 0.132 | Alkaline phosphatase inhibitor | 0.113 0.095 DBMET00016 0.111 0.099 DBMET00017 | ||
| 0.063 | 0.005 | 0.063 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 DBMET00016 0.034 0.012 DBMET00017 0.023 0.021 DBMET01049 | ||
| 0.224 | 0.168 | 0.398 | Calpain 2 inhibitor | 0.398 0.062 DBMET00017 0.306 0.11 DBMET01048 | DBMET00017 | |
| 0.067 | 0.01 | 0.069 | Benzodiazepine inverse agonist | 0.058 0.016 DBMET00017 0.053 0.021 DBMET00015 0.069 0.009 DBMET01049 | DBMET01049 | |
| 0.105 | 0.049 | 0.105 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.098 0.055 DBMET00017 0.094 0.058 DBMET00015 | ||
| 0.065 | 0.015 | 0.065 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.026 DBMET00016 | ||
| 0.216 | 0.166 | 0.415 | Sodium/bile acid cotransporter inhibitor | 0.235 0.145 DBMET00016 0.254 0.124 DBMET00017 0.22 0.162 DBMET03017 0.27 0.108 DBMET01048 0.216 0.166 DBMET01049 0.415 0.013 DBMET01050 | DBMET01050 | |
| 0.143 | 0.096 | 0.143 | Mcl-1 antagonist | 0.124 0.12 DBMET00016 0.131 0.11 DBMET00017 | ||
| 0.129 | 0.087 | 0.152 | Mannose-6-phosphate isomerase inhibitor | 0.125 0.093 DBMET00016 0.127 0.089 DBMET03017 0.152 0.063 DBMET01049 | DBMET01049 | |
| 0.184 | 0.144 | 0.303 | Streptokinase A inhibitor | 0.193 0.138 DBMET00017 0.303 0.078 DBMET01049 | DBMET01049 | |
| 0.198 | 0.158 | 0.198 | Prostaglandin dehydrogenase inhibitor | |||
| 0.154 | 0.116 | 0.154 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.057 | 0.021 | 0.066 | Carbonic anhydrase IV inhibitor | 0.051 0.024 DBMET00016 0.066 0.016 DBMET00017 0.059 0.02 DBMET01048 | DBMET00017 | |
| 0.066 | 0.032 | 0.089 | Potassium channel Kv1.5 blocker | 0.089 0.022 DBMET00017 0.054 0.043 DBMET01049 | DBMET00017 | |
| 0.04 | 0.006 | 0.04 | Myristoyl transferase inhibitor | 0.035 0.008 DBMET00017 0.035 0.009 DBMET01049 | ||
| 0.099 | 0.064 | 0.099 | Cyclin-dependent kinase 9 inhibitor | 0.09 0.075 DBMET01049 | ||
| 0.059 | 0.025 | 0.071 | Carbonic anhydrase XIV inhibitor | 0.071 0.02 DBMET00016 0.047 0.036 DBMET00017 0.053 0.03 DBMET01048 | DBMET00016 | |
| 0.051 | 0.019 | 0.051 | GHS receptor agonist | 0.041 0.032 DBMET00017 0.042 0.03 DBMET01049 0.042 0.031 DBMET01050 | ||
| 0.068 | 0.037 | 0.068 | Raf kinase C inhibitor | 0.067 0.037 DBMET00017 | ||
| 0.139 | 0.109 | 0.139 | LIM domain kinase 1 inhibitor | |||
| 0.058 | 0.028 | 0.071 | Factor IXa inhibitor | 0.057 0.029 DBMET00016 0.065 0.023 DBMET00017 0.071 0.02 DBMET03017 0.062 0.025 DBMET01048 | DBMET03017 | |
| 0.071 | 0.042 | 0.071 | Bcl2 antagonist | 0.063 0.05 DBMET00016 0.07 0.043 DBMET01049 | ||
| 0.062 | 0.034 | 0.069 | Carbonic anhydrase I inhibitor | 0.056 0.038 DBMET00016 0.069 0.029 DBMET00017 0.059 0.036 DBMET01048 | DBMET00017 | |
| 0.11 | 0.084 | 0.144 | MAP kinase kinase inhibitor | 0.101 0.094 DBMET00016 0.144 0.055 DBMET00015 | DBMET00015 | |
| 0.062 | 0.036 | 0.062 | Bcl-xL inhibitor | 0.062 0.033 DBMET00016 0.056 0.053 DBMET01048 0.06 0.039 DBMET01049 | ||
| 0.032 | 0.007 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.012 DBMET00016 | ||
| 0.036 | 0.012 | 0.039 | Kynurenine 3 monooxygenase inhibitor | 0.039 0.01 DBMET00016 | DBMET00016 | |
| 0.059 | 0.037 | 0.059 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.072 | 0.052 | 0.076 | Raf kinase inhibitor | 0.076 0.049 DBMET00017 | DBMET00017 | |
| 0.032 | 0.014 | 0.032 | 5 Hydroxytryptamine 6 agonist | |||
| 0.194 | 0.177 | 0.289 | Thioredoxin glutathione reductase inhibitor | 0.265 0.125 DBMET00017 0.228 0.15 DBMET01048 0.289 0.109 DBMET01049 | DBMET01049 | |
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) agonist | |||
| 0.037 | 0.021 | 0.037 | AMPA receptor agonist | 0.035 0.025 DBMET00016 0.036 0.024 DBMET01050 | ||
| 0.021 | 0.006 | 0.021 | CC chemokine 9 receptor antagonist | 0.021 0.006 DBMET01049 | ||
| 0.044 | 0.031 | 0.051 | AICAR transformylase inhibitor | 0.051 0.021 DBMET00016 0.041 0.036 DBMET01048 | DBMET00016 | |
| 0.018 | 0.005 | 0.018 | CC chemokine 10 receptor antagonist | 0.016 0.009 DBMET00016 | ||
| 0.031 | 0.02 | 0.037 | LIM domain kinase 2 inhibitor | 0.037 0.012 DBMET00017 | DBMET00017 | |
| 0.09 | 0.079 | 0.106 | GABA C receptor agonist | 0.106 0.061 DBMET00016 | DBMET00016 | |
| 0.014 | 0.005 | 0.015 | 2-Acylglycerol O-acyltransferase 2 inhibitor | 0.013 0.005 DBMET00017 0.009 0.008 DBMET00015 0.015 0.005 DBMET01049 | DBMET01049 | |
| 0.024 | 0.014 | 0.024 | CC chemokine 8 receptor antagonist | 0.022 0.02 DBMET01049 | ||
| 0.033 | 0.025 | 0.033 | Glutamate (mGluR4) agonist | |||
| 0.042 | 0.038 | 0.054 | Carbonic anhydrase VII inhibitor | 0.054 0.024 DBMET00017 0.049 0.028 DBMET01048 | DBMET00017 | |
| 0.016 | 0.012 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.013 DBMET01049 | ||
| 0.05 | 0.047 | 0.05 | Bombesin 3 receptor antagonist | |||
| 0.047 | 0.045 | 0.047 | Alpha 1b adrenoreceptor agonist | |||
| 0.024 | 0.025 | 0.027 | Integrin alpha2beta1 antagonist | 0.027 0.016 DBMET00016 | DBMET00016 | |
| 0.049 | 0.052 | 0.051 | Raf kinase B inhibitor | 0.051 0.05 DBMET00017 | DBMET00017 | |
| 0.018 | 0.022 | 0.02 | Factor XIII inhibitor | 0.02 0.015 DBMET00017 | DBMET00017 | |
| 0.032 | 0.037 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 DBMET00016 | DBMET00016 | |
| 0.169 | 0.183 | 0.22 | Neuropeptide Y2 antagonist | 0.22 0.089 DBMET00017 | DBMET00017 | |
| 0.039 | 0.053 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.052 0.033 DBMET00016 0.055 0.03 DBMET01048 | DBMET01048 | |
| 0.059 | 0.073 | 0.074 | Thrombin inhibitor | 0.074 0.049 DBMET01050 | DBMET01050 | |
| 0.112 | 0.128 | 0.282 | Aurora-C kinase inhibitor | 0.137 0.069 DBMET00017 0.282 0.005 DBMET01049 | DBMET01049 | |
| 0.039 | 0.057 | 0.046 | Phosphatidylinositol 3-kinase beta inhibitor | 0.046 0.04 DBMET00017 | DBMET00017 | |
| 0.055 | 0.073 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.062 0.049 DBMET00016 0.063 0.048 DBMET00017 0.071 0.032 DBMET01048 | DBMET01048 | |
| 0.045 | 0.066 | 0.073 | Carbonic anhydrase stimulant | 0.073 0.029 DBMET01050 | DBMET01050 | |
| 0.057 | 0.078 | 0.096 | Epoxide hydrolase inhibitor | 0.096 0.028 DBMET00017 | DBMET00017 | |
| 0.04 | 0.063 | 0.048 | CXC chemokine 1 receptor antagonist | 0.048 0.042 DBMET00017 | DBMET00017 | |
| 0.031 | 0.055 | 0.049 | Aggrecanase 1 inhibitor | 0.049 0.014 DBMET00015 | DBMET00015 | |
| 0.13 | 0.155 | 0.188 | Phospholipase C inhibitor | 0.14 0.129 DBMET00016 0.188 0.053 DBMET01050 | DBMET01050 | |
| 0.039 | 0.068 | 0.061 | Beta 1 adrenoreceptor antagonist | 0.053 0.043 DBMET00016 0.061 0.035 DBMET01048 | DBMET01048 | |
| 0.174 | 0.203 | 0.223 | Angiogenesis inhibitor | 0.223 0.145 DBMET00017 | DBMET00017 | |
| 0.043 | 0.073 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.043 DBMET00016 0.05 0.047 DBMET01048 | DBMET00016 | |
| 0.04 | 0.073 | 0.061 | Carbonic anhydrase II stimulant | 0.061 0.022 DBMET01050 | DBMET01050 | |
| 0.051 | 0.085 | 0.058 | Trypsin inhibitor | 0.058 0.052 DBMET01050 | DBMET01050 | |
| 0.115 | 0.154 | 0.26 | Pyruvate kinase inhibitor | 0.26 0.058 DBMET01049 | DBMET01049 | |
| 0.22 | 0.271 | 0.324 | MAP kinase 1 inhibitor | 0.324 0.156 DBMET01049 | DBMET01049 | |
| 0.032 | 0.083 | 0.045 | Purinergic P2X4 antagonist | 0.045 0.033 DBMET00017 | DBMET00017 | |
| 0.02 | 0.073 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | 0.031 0.029 DBMET00017 | DBMET00017 | |
| 0.019 | 0.076 | 0.049 | Carbonic anhydrase I stimulant | 0.049 0.017 DBMET01050 | DBMET01050 | |
| 0.152 | 0.209 | 0.166 | 5 Hydroxytryptamine 3E antagonist | 0.166 0.149 DBMET00017 | DBMET00017 | |
| 0.05 | 0.113 | 0.111 | Metalloproteinase-2 inhibitor | 0.075 0.058 DBMET00015 0.07 0.066 DBMET01048 0.111 0.033 DBMET01050 | DBMET01050 | |
| 0.048 | 0.115 | 0.062 | Kallikrein 7 inhibitor | 0.062 0.048 DBMET00017 | DBMET00017 | |
| 0.014 | 0.085 | 0.055 | Calcium-sensing receptor agonist | 0.055 0.005 DBMET01050 | DBMET01050 | |
| 0.061 | 0.136 | 0.089 | NADH dehydrogenase inhibitor | 0.088 0.06 DBMET00016 0.089 0.058 DBMET03017 | DBMET03017 | |
| 0.034 | 0.111 | 0.054 | Cyclin H inhibitor | 0.054 0.047 DBMET01049 | DBMET01049 | |
| 0.116 | 0.193 | 0.491 | Immunostimulant | 0.198 0.122 DBMET00016 0.464 0.034 DBMET03017 0.175 0.136 DBMET00015 0.215 0.111 DBMET01048 0.491 0.03 DBMET01050 | DBMET01050 | |
| 0.019 | 0.096 | 0.043 | Macrophage elastase inhibitor | 0.039 0.034 DBMET00015 0.043 0.03 DBMET01050 | DBMET01050 | |
| 0.098 | 0.176 | 0.148 | Heat shock protein 90 alpha antagonist | 0.148 0.089 DBMET01049 | DBMET01049 | |
| 0.142 | 0.22 | 0.289 | Thyroid hormone antagonist | 0.289 0.099 DBMET00017 | DBMET00017 | |
| 0.038 | 0.118 | 0.065 | NMDA receptor agonist | 0.065 0.04 DBMET01050 | DBMET01050 | |
| 0.047 | 0.129 | 0.069 | Metalloproteinase-9 inhibitor | 0.069 0.057 DBMET01050 | DBMET01050 | |
| 0.055 | 0.14 | 0.081 | HIV-1 integrase (Overall Integration) inhibitor | 0.081 0.076 DBMET00016 | DBMET00016 | |
| 0.136 | 0.222 | 0.286 | Thyroid hormone beta antagonist | 0.286 0.095 DBMET00017 | DBMET00017 | |
| 0.055 | 0.143 | 0.264 | Glutathione S-transferase inhibitor | 0.264 0.004 DBMET01050 | DBMET01050 | |
| 0.032 | 0.122 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.027 DBMET00016 0.046 0.028 DBMET01048 | DBMET01048 | |
| 0.025 | 0.116 | 0.078 | Neutrophil collagenase inhibitor | 0.078 0.033 DBMET01050 | DBMET01050 | |
| 0.043 | 0.142 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.039 DBMET01050 | DBMET01050 | |
| 0.019 | 0.122 | 0.042 | Thymidylate synthase inhibitor | 0.042 0.038 DBMET01050 | DBMET01050 | |
| 0.044 | 0.159 | 0.266 | Aminopeptidase B inhibitor | 0.266 0.011 DBMET01050 | DBMET01050 | |
| 0.122 | 0.24 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.135 DBMET00016 | DBMET00016 | |
| 0.057 | 0.182 | 0.104 | Proteasome inhibitor | 0.104 0.082 DBMET01050 | DBMET01050 | |
| 0.055 | 0.18 | 0.093 | Thioredoxin inhibitor | 0.093 0.057 DBMET00016 | DBMET00016 | |
| 0.057 | 0.184 | 0.1 | Amylase inhibitor | 0.1 0.097 DBMET00016 | DBMET00016 | |
| 0.027 | 0.17 | 0.06 | Heparanase inhibitor | 0.06 0.023 DBMET03017 | DBMET03017 | |
| 0.085 | 0.229 | 0.21 | Insulin sensitizer | 0.21 0.064 DBMET01050 | DBMET01050 | |
| 0.038 | 0.184 | 0.08 | Adrenaline agonist | 0.08 0.058 DBMET00016 | DBMET00016 | |
| 0.149 | 0.3 | 0.484 | Antibacterial | 0.241 0.186 DBMET00016 0.484 0.045 DBMET03017 | DBMET03017 | |
| 0.008 | 0.159 | 0.047 | Histone deacetylase class IIa inhibitor | 0.047 0.015 DBMET00015 | DBMET00015 | |
| 0.056 | 0.208 | 0.112 | M17 leucyl aminopeptidase inhibitor | 0.112 0.086 DBMET00017 | DBMET00017 | |
| 0.041 | 0.194 | 0.107 | Protease inhibitor | 0.107 0.059 DBMET01050 | DBMET01050 | |
| 0.021 | 0.176 | 0.059 | Phosphofructokinase-1 inhibitor | 0.059 0.058 DBMET03017 | DBMET03017 | |
| 0.147 | 0.306 | 0.314 | Interleukin 2 agonist | 0.257 0.111 DBMET00016 0.217 0.161 DBMET00017 0.314 0.064 DBMET03017 0.296 0.076 DBMET01048 0.262 0.106 DBMET01050 | DBMET03017 | |
| 0.095 | 0.269 | 0.181 | Calpain inhibitor | 0.178 0.137 DBMET00017 0.181 0.134 DBMET01050 | DBMET01050 | |
| 0.045 | 0.222 | 0.089 | Triose-phosphate isomerase inhibitor | 0.089 0.061 DBMET03017 | DBMET03017 | |
| 0.062 | 0.24 | 0.12 | CDK3/cyclin E inhibitor | 0.12 0.055 DBMET00017 0.112 0.067 DBMET01048 | DBMET00017 | |
| 0.027 | 0.211 | 0.082 | Aminopeptidase I inhibitor | 0.082 0.04 DBMET01050 | DBMET01050 | |
| 0.049 | 0.233 | 0.109 | Caspase 3 inhibitor | 0.104 0.085 DBMET00017 0.106 0.081 DBMET01048 0.109 0.077 DBMET01050 | DBMET01050 | |
| 0.06 | 0.25 | 0.129 | Peroxidase inhibitor | 0.129 0.092 DBMET01050 | DBMET01050 | |
| 0.021 | 0.21 | 0.085 | Nitric oxide donor | 0.085 0.018 DBMET03017 0.056 0.055 DBMET01049 0.07 0.033 DBMET01050 | DBMET03017 | |
| 0.013 | 0.202 | 0.047 | Collagenase inhibitor | 0.047 0.039 DBMET00015 0.045 0.044 DBMET01050 | DBMET00015 | |
| 0.036 | 0.228 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.048 DBMET00016 0.059 0.056 DBMET01048 | DBMET00016 | |
| 0.049 | 0.245 | 0.099 | Transcription factor NF kappa B stimulant | 0.099 0.039 DBMET03017 0.084 0.061 DBMET01050 | DBMET03017 | |
| 0.021 | 0.227 | 0.144 | Histidine decarboxylase inhibitor | 0.144 0.02 DBMET01050 | DBMET01050 | |
| 0.006 | 0.225 | 0.052 | Histone deacetylase 5 inhibitor | 0.052 0.016 DBMET00015 | DBMET00015 | |
| 0.086 | 0.307 | 0.157 | ATPase inhibitor | 0.157 0.089 DBMET03017 | DBMET03017 | |
| 0.052 | 0.275 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 DBMET01049 | DBMET01049 | |
| 0.036 | 0.266 | 0.09 | UDP-glucose 4-epimerase inhibitor | 0.09 0.073 DBMET03017 | DBMET03017 | |
| 0.094 | 0.338 | 0.226 | Transcription factor STAT3 inhibitor | 0.199 0.135 DBMET00017 0.226 0.105 DBMET01048 0.176 0.169 DBMET01049 | DBMET01048 | |
| 0.006 | 0.256 | 0.05 | Histone deacetylase class II inhibitor | 0.05 0.011 DBMET00015 | DBMET00015 | |
| 0.018 | 0.276 | 0.108 | Glutamate decarboxylase inhibitor | 0.108 0.026 DBMET01050 | DBMET01050 | |
| 0.006 | 0.266 | 0.034 | Histone deacetylase 4 inhibitor | 0.034 0.021 DBMET00015 | DBMET00015 | |
| 0.009 | 0.273 | 0.041 | Integrin alpha5beta1 antagonist | 0.041 0.027 DBMET01050 | DBMET01050 | |
| 0.092 | 0.368 | 0.151 | Cyclin-dependent kinase 3 inhibitor | 0.149 0.097 DBMET00017 0.151 0.093 DBMET01048 | DBMET01048 | |
| 0.094 | 0.377 | 0.293 | Immunomodulator | 0.293 0.086 DBMET01050 | DBMET01050 | |
| 0.058 | 0.346 | 0.134 | Factor V inhibitor | 0.134 0.027 DBMET01050 | DBMET01050 | |
| 0.088 | 0.378 | 0.276 | Antithrombotic | 0.276 0.106 DBMET03017 0.238 0.136 DBMET01050 | DBMET03017 | |
| 0.052 | 0.355 | 0.19 | Thiol protease inhibitor | 0.19 0.043 DBMET01050 | DBMET01050 | |
| 0.035 | 0.342 | 0.147 | Alpha-N-acetylglucosaminidase inhibitor | 0.147 0.057 DBMET01048 | DBMET01048 | |
| 0.013 | 0.353 | 0.091 | Cyclin-dependent kinase 1 inhibitor | 0.091 0.073 DBMET01049 | DBMET01049 | |
| 0.015 | 0.358 | 0.066 | CDK1/cyclin B1 inhibitor | 0.066 0.052 DBMET01049 | DBMET01049 | |
| 0.025 | 0.385 | 0.143 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.143 0.016 DBMET01049 | DBMET01049 | |
| 0.034 | 0.398 | 0.193 | Anticoagulant | 0.193 0.056 DBMET01050 | DBMET01050 | |
| 0.066 | 0.431 | 0.19 | Transcription factor STAT inhibitor | 0.19 0.153 DBMET01048 | DBMET01048 | |
| 0.038 | 0.406 | 0.185 | Death-associated protein kinase 3 inhibitor | 0.185 0.084 DBMET01049 | DBMET01049 | |
| 0.014 | 0.398 | 0.034 | Glutamate (mGluR8) antagonist | 0.034 0.028 DBMET01050 | DBMET01050 | |
| 0.067 | 0.468 | 0.531 | Death-associated protein kinase 2 inhibitor | 0.167 0.072 DBMET00017 0.143 0.123 DBMET01048 0.531 0.003 DBMET01049 | DBMET01049 | |
| 0.046 | 0.449 | 0.11 | Folate antagonist | 0.11 0.049 DBMET01050 | DBMET01050 | |
| 0.03 | 0.438 | 0.119 | Nav1.4 sodium channel blocker | 0.119 0.052 DBMET01050 | DBMET01050 | |
| 0.098 | 0.536 | 0.514 | Antiinflammatory | 0.514 0.082 DBMET03017 | DBMET03017 | |
| 0.087 | 0.537 | 0.312 | Peptidyltransferase inhibitor | 0.312 0.021 DBMET03017 0.177 0.133 DBMET01048 0.246 0.054 DBMET01050 | DBMET03017 | |
| 0.02 | 0.482 | 0.18 | Chelator | 0.18 0.028 DBMET01050 | DBMET01050 | |
| 0.008 | 0.487 | 0.139 | Cyclin-dependent kinase 5 inhibitor | 0.139 0.047 DBMET01049 | DBMET01049 | |
| 0.003 | 0.509 | 0.045 | GP IIb/IIIa receptor antagonist | 0.045 0.037 DBMET01050 | DBMET01050 | |
| 0.006 | 0.52 | 0.077 | Cyclin B inhibitor | 0.077 0.017 DBMET01049 | DBMET01049 | |
| 0.025 | 0.546 | 0.091 | Toll-Like receptor 4 antagonist | 0.091 0.087 DBMET03017 | DBMET03017 | |
| 0.008 | 0.538 | 0.118 | MAP kinase 10 inhibitor | 0.118 0.025 DBMET01049 | DBMET01049 | |
| 0.03 | 0.569 | 0.143 | Platelet adhesion inhibitor | 0.143 0.114 DBMET03017 | DBMET03017 | |
| 0.004 | 0.546 | 0.035 | Histone deacetylase class IIb inhibitor | 0.035 0.014 DBMET00015 | DBMET00015 | |
| 0.008 | 0.552 | 0.051 | Erythropoietin receptor agonist | 0.051 0.021 DBMET01050 | DBMET01050 | |
| 0.018 | 0.564 | 0.107 | Bone formation stimulant | 0.107 0.098 DBMET01050 | DBMET01050 | |
| 0.004 | 0.55 | 0.034 | Histone deacetylase 6 inhibitor | 0.034 0.014 DBMET00015 | DBMET00015 | |
| 0.008 | 0.561 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET01048 | DBMET01048 | |
| 0.02 | 0.577 | 0.259 | Platelet antagonist | 0.259 0.069 DBMET01050 | DBMET01050 | |
| 0.005 | 0.576 | 0.066 | Cyclin B2 inhibitor | 0.066 0.025 DBMET01049 | DBMET01049 | |
| 0.013 | 0.676 | 0.097 | Factor XII inhibitor | 0.097 0.04 DBMET01049 0.086 0.055 DBMET01050 | DBMET01049 | |
| 0.014 | 0.682 | 0.549 | Angiogenesis stimulant | 0.549 0.009 DBMET03017 0.234 0.078 DBMET01050 | DBMET03017 | |
| 0.009 | 0.686 | 0.031 | ADAM10 endopeptidase inhibitor | 0.031 0.029 DBMET00015 | DBMET00015 | |
| 0.01 | 0.695 | 0.039 | Cathepsin F inhibitor | 0.039 0.036 DBMET01050 | DBMET01050 | |
| 0.007 | 0.713 | 0.055 | Protein 50S ribosomal subunit inhibitor | 0.055 0.035 DBMET03017 | DBMET03017 | |
| 0.013 | 0.722 | 0.083 | Somatostatin 1 agonist | 0.083 0.048 DBMET01050 | DBMET01050 | |
| 0.032 | 0.791 | 0.225 | Apoptosis antagonist | 0.225 0.152 DBMET01050 | DBMET01050 | |
| 0.004 | 0.77 | 0.079 | Glucagon-like peptide 1 agonist | 0.079 0.036 DBMET01050 | DBMET01050 | |
| 0.023 | 0.802 | 0.243 | Hepatoprotectant | 0.243 0.045 DBMET03017 0.224 0.052 DBMET01050 | DBMET03017 | |
| 0.018 | 0.805 | 0.324 | Cyclophilin D inhibitor | 0.324 0.142 DBMET03017 | DBMET03017 | |
| 0.007 | 0.801 | 0.047 | Antibiotic Aminoglycoside-like | 0.047 0.015 DBMET03017 | DBMET03017 | |
| 0.007 | 0.856 | 0.17 | Nitric oxide antagonist | 0.17 0.081 DBMET03017 | DBMET03017 | |
| 0.004 | 0.875 | 0.061 | Aminopeptidase N inhibitor | 0.061 0.024 DBMET01050 | DBMET01050 | |
| 0.004 | 0.877 | 0.082 | Aminopeptidase microsomal inhibitor | 0.082 0.024 DBMET01050 | DBMET01050 | |
| 0.01 | 0.888 | 0.235 | Apoptosis agonist | 0.235 0.231 DBMET03017 | DBMET03017 | |
| 0.011 | 0.904 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.04 DBMET01050 | DBMET01050 | |
| 0.006 | 0.9 | 0.221 | Thrombolytic | 0.221 0.043 DBMET01050 | DBMET01050 | |
| 0.024 | 0.919 | 0.196 | Growth hormone agonist | 0.196 0.06 DBMET01050 | DBMET01050 | |
| 0.03 | 0.927 | 0.281 | Death-associated protein kinase 1 inhibitor | 0.281 0.004 DBMET01049 | DBMET01049 | |
| 0.003 | 0.918 | 0.166 | Selectin antagonist | 0.166 0.015 DBMET03017 | DBMET03017 | |
| 0.002 | 0.918 | 0.164 | Antineoplastic antibiotic | 0.164 0.028 DBMET03017 | DBMET03017 | |
| 0.013 | 0.931 | 0.099 | Hematopoietic | 0.099 0.037 DBMET01050 | DBMET01050 | |
| 0.004 | 0.934 | 0.201 | Antioxidant | 0.201 0.112 DBMET03017 | DBMET03017 | |
| 0.008 | 0.943 | 0.11 | Histone deacetylase SIRT1 inhibitor | 0.11 0.104 DBMET01050 | DBMET01050 | |
| 0.004 | 0.94 | 0.165 | Free radical scavenger | 0.165 0.128 DBMET03017 | DBMET03017 | |
| 0.003 | 0.95 | 0.055 | Angiotensin-converting enzyme inhibitor | 0.055 0.037 DBMET01050 | DBMET01050 | |
| 0.004 | 0.981 | 0.216 | Interleukin antagonist | 0.216 0.076 DBMET01050 | DBMET01050 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |